Related Experiment Videos

Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis

T G Cotter1, S V Lennon, J M Glynn

  • 1Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology, California 92037.

Cancer Research
|February 15, 1992
PubMed

Insights

Cytochalasin B inhibits later stages of apoptosis, specifically cell fragmentation and apoptotic body formation, by interfering with actin polymerization. This highlights the necessity of microfilament assembly for these late-stage apoptotic events.

Area of Science:

  • Cell Biology
  • Biochemistry

Background:

  • Apoptosis is an ordered process of programmed cell death.
  • Key early events include DNA fragmentation and cell shrinkage.
  • Later stages involve cell fragmentation into apoptotic bodies.

Purpose of the Study:

  • To investigate the role of microfilament assembly in apoptosis.
  • To determine if cytochalasin B affects specific stages of apoptosis.

Main Methods:

  • Treatment of HL-60, Molt-4, and U-937 cell lines with cytochalasin B.
  • Induction of apoptosis using agents like UV irradiation, camptothecin, and staurosporin.
  • Observation of DNA fragmentation, nuclear fragmentation, and apoptotic body formation.

Main Results:

  • Cytochalasin B inhibited cell fragmentation and apoptotic body formation.
  • This inhibition occurred without affecting early DNA or nuclear fragmentation.
  • Staurosporin showed similar effects, suggesting involvement of protein kinase C and microfilaments.

Conclusions:

  • Microfilament assembly is essential for the formation of apoptotic bodies in late-stage apoptosis.
  • Cytochalasin B's interference with actin polymerization disrupts this process.
  • These findings elucidate the molecular mechanisms underlying apoptotic morphology.

Related Concept Videos